共 50 条
- [1] Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisCLINICAL RHEUMATOLOGY, 2023, 42 (12) : 3397 - 3405Weinstein, Cindy L. J.Meehan, Alan G.Lin, JianxinBriscoe, Steven D.Govoni, Marinella
- [2] LONG-TERM GOLIMUMAB PERSISTENCE: 5-YEAR TREATMENT RETENTION DATA POOLED FROM FIVE PHASE III CLINICAL TRIALS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITISANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 777 - 778Weinstein, C.Govoni, M.Lin, J.Meehan, A.Qureshi, Z.
- [3] Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisJOURNAL OF RHEUMATOLOGY, 2016, 43 (12) : 2120 - 2130Kay, JonathanFleischmann, RoyKeystone, EdwardHsia, Elizabeth C.Hsu, BenjaminZhou, YiyingGoldstein, NeilBraun, Juergen
- [4] Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registryCLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (05) : 804 - 809Manara, M.Caporali, R.Favalli, E. G.Grosso, V.Atzeni, F.Sarzi-Puttini, P.Gorla, R.Bazzani, C.Fusaro, E.Pellerito, R.Rocchetta, P. A.Sinigaglia, L.
- [5] Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisArthritis Research & Therapy, 24M. Elaine HusniAtul DeodharSergio SchwartzmanSoumya D. ChakravartyElizabeth C. HsiaJocelyn H. LeuYiying ZhouKim H. LoArthur Kavanaugh
- [6] Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)Husni, M. ElaineDeodhar, AtulSchwartzman, SergioChakravarty, Soumya D.Hsia, Elizabeth C.Leu, Jocelyn H.Zhou, YiyingLo, Kim H.Kavanaugh, Arthur
- [7] Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritisMUSCULOSKELETAL CARE, 2023, 21 (01) : 189 - 197Pombo-Suarez, ManuelSeoane-Mato, DanielDiaz-Gonzalez, FedericoCea-Calvo, LuisSanchez-Alonso, FernandoSanchez-Jareno, MartaJovani, VegaGarcia-Magallon, BlancaMartinez-Gonzalez, OlgaCampos-Fernandez, CristinaManero, JavierDiaz-Torne, CesarBohorquez, CristinaRos-Vilamajo, InmaculadaPerez-Vera, YaniraCastrejon, Isabel
- [8] Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) : 538 - 546Kay, JonathanFleischmann, RoyKeystone, EdwardHsia, Elizabeth C.Hsu, BenjaminMack, MichaelGoldstein, NeilBraun, JuergenKavanaugh, Arthur
- [9] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITISRHEUMATOLOGY, 2022, 61Shaw, TimBurmester, Gerd R.Cohen, Stanley B.Winthrop, KevinNash, PeterRubbert-Roth, AndreaDeodhar, AtulElkayam, OriMysler, EduardoTanaka, YoshiyaLiu, JianzhongLacerda, Ana PaulaPierre-Louis, Bosny J.Mease, Philip J.
- [10] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITISINTERNAL MEDICINE JOURNAL, 2022, 52 : 27 - 27Nash, PeterBurmester, Gerd R.Cohen, Stanley B.Winthrop, KevinRubbert-Roth, AndreaDeodhar, AtulElkayam, OriMysler, EduardoTanaka, YoshiyaLiu, JianzhongLacerda, Ana P.Pierre-Louis, Bosny J.Shaw, TimMease, Philip J.